Mer­ck de­tails win for Keytru­da in blad­der can­cer af­ter surgery

Mer­ck’s top-sell­ing can­cer drug Keytru­da cut the risk of blad­der can­cer com­ing back or death af­ter surgery by 31%, ac­cord­ing to new da­ta shared Fri­day …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA